This is a StreetInsider.com Premium Only Page

(PAVMZ) – Business Wire

Jan 17, 2023 04:05 PM PAVmed and Lucid Diagnostics Provide Strategic Business Update

Jan 11, 2023 08:00 AM PAVmed and Lucid Diagnostics to Provide Strategic Business Update

Dec 22, 2022 08:25 AM PAVmed Partners with Novosound on Ultrasound Imaging Technology

Dec 15, 2022 08:25 AM PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform

Dec 8, 2022 08:25 AM Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry

Dec 1, 2022 08:25 AM Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research

Nov 15, 2022 04:20 PM PAVmed Provides Business Update and Third Quarter 2022 Financial Results

Nov 14, 2022 04:40 PM Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results

Nov 11, 2022 08:25 AM PAVmed to Participate in BTIG Digital Health Forum

Nov 10, 2022 08:25 AM Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum

Nov 9, 2022 08:25 AM Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer

Nov 3, 2022 08:25 AM PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022

Nov 2, 2022 08:25 AM Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022

Aug 30, 2022 08:25 AM PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference

Aug 16, 2022 04:40 PM PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results

Aug 15, 2022 04:25 PM Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results

Aug 11, 2022 08:25 AM Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio

Aug 4, 2022 08:25 AM Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies

Aug 3, 2022 08:25 AM PAVmed to Hold a Business Update Conference Call on August 16, 2022

Aug 2, 2022 08:25 AM Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements

Aug 1, 2022 08:25 AM Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022

Jul 19, 2022 08:25 AM PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America

Jul 18, 2022 08:25 AM Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference

May 13, 2022 08:25 AM PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO

May 12, 2022 04:38 PM PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

May 11, 2022 04:00 PM Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results

May 9, 2022 08:25 AM Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans

Apr 26, 2022 08:25 AM PAVmed to Hold a Business Update Conference Call on May 12, 2022

Apr 25, 2022 08:25 AM Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022

Apr 4, 2022 08:25 AM Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination

Mar 30, 2022 08:25 AM Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference

Mar 29, 2022 04:11 PM PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results

Mar 28, 2022 04:47 PM Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results

Mar 24, 2022 08:25 AM PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study

Mar 23, 2022 08:25 AM PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

Mar 17, 2022 08:25 AM PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System

Mar 10, 2022 08:25 AM PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board

Mar 8, 2022 08:30 AM PAVmed to Hold a Business Update Conference Call on March 29, 2022

Mar 7, 2022 08:30 AM Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022

Mar 4, 2022 08:25 AM Lucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech Summit

Mar 3, 2022 08:25 AM PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth

Feb 24, 2022 08:25 AM PAVmed Appoints Shaun O’Neil as Chief Operating Officer

Feb 15, 2022 08:25 AM Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

Feb 10, 2022 08:25 AM Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

Jan 12, 2022 08:25 AM PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

Jan 6, 2022 08:30 AM Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference

Dec 1, 2021 08:30 AM PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth

Nov 17, 2021 08:30 AM Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Nov 16, 2021 04:13 PM PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results

Nov 11, 2021 08:30 AM PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers